www.taro.com

Trademarks and Copyright© The images and information contained in the Site are, to the fullest extent possible, copyrighted and otherwise proprietary. It is the policy of Taro to enforce its intellectual property rights to the fullest extent of the law, including (where applicable) seeking criminal sanctions.

News Release
<< Back
Taro to Announce Third Quarter Results on February 7, 2018

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Jan. 31, 2018-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2017, after the close of market on Wednesday, February 7, 2018.

The release will be accessible on Taro’s website at www.taro.com.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

Source: Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.
Mariano Balaguer
VP, Chief Financial Officer
914-345-9001
Mariano.Balaguer@Taro.com
or
William J. Coote
AVP, Business Finance, Treasurer and Investor Relations
914-345-9001
William.Coote@Taro.com

Terms of Use
  |  
Privacy Statement
  |  
Safe Harbor Statement